Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,869 | 102,029 | 154,654 | 162,449 | 15,818 |
| Marketable Securities | 42,334 | 42,639 | N/A | N/A | 0 |
| Receivables | 734 | 1,738 | 754 | 674 | 1,476 |
| Other current assets | 0 | 0 | 0 | 0 | 928 |
| TOTAL | $136,505 | $150,868 | $160,423 | $163,670 | $18,222 |
| Non-Current Assets | |||||
| PPE Net | 1,445 | 1,427 | 1,112 | 1,188 | 1,451 |
| Other Non-Current Assets | 1,297 | 1,255 | 1,040 | 1,073 | 715 |
| TOTAL | $2,742 | $2,682 | $2,152 | $2,261 | $2,166 |
| Total Assets | $139,247 | $153,550 | $162,575 | $165,930 | $20,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,553 | 1,941 | 2,193 | 1,765 | 868 |
| Accrued Expenses | 1,879 | 3,003 | 1,938 | 3,764 | 1,556 |
| Other current liabilities | 5,028 | 5,232 | 5,587 | 9,206 | 4,055 |
| TOTAL | $11,248 | $13,211 | $13,882 | $19,395 | $7,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,284 | 4,150 | 3,930 | 3,629 | 3,604 |
| Deferred Revenues | 1,527 | 2,689 | 3,870 | 4,399 | N/A |
| Other Non-Current Liabilities | 5,028 | 5,232 | 5,346 | 5,349 | 0 |
| TOTAL | $9,632 | $9,706 | $9,424 | $9,735 | $5,547 |
| Total Liabilities | $20,880 | $22,917 | $23,305 | $29,130 | $12,865 |
| Shareholders' Equity | |||||
| Common Shares | 3,653 | 3,647 | 3,727 | 3,634 | 0 |
| Retained earnings | -76,162 | -69,842 | -62,371 | -55,434 | -33,386 |
| Other shareholders' equity | -1,394 | 4,838 | 1,740 | 1,788 | 845 |
| TOTAL | $118,367 | $130,633 | $139,270 | $136,801 | $7,621 |
| Total Liabilities And Equity | $139,247 | $153,550 | $162,575 | $165,930 | $20,486 |